Cytotoxic T-Lymphocyte
Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. These cells are distinct from natural killer cells and from killer cells mediating antibody-dependent cell cytotoxicity. [ ]
Term info
Cytotoxic T-Lymphocyte
- CTL
- Cytolytic T-Cell
- Cytotoxic T Cell
- Cytotoxic T Cells
- Cytotoxic T-Lymphocyte
- Cytotoxic T-Lymphocytes
- T-Lymphocyte, Cytotoxic
- T-Lymphocytes, Cytotoxic
- cytotoxic T cell
- cytotoxic T lymphocyte
- killer T cell
NCIT_C116977, NCIT_C142799
A type of immune cell that can kill certain cells, including foreign cells, cancer cells, and cells infected with a virus. Cytotoxic T lymphocytes can be separated from other blood cells, grown in the laboratory, and then given to a patient to kill cancer cells. A cytotoxic T lymphocyte is a type of white blood cell and a type of lymphocyte.
CTRP
Cytotoxic T-Lymphocyte
Cytotoxic_T-Lymphocyte
Cytotoxic T-Lymphocyte
Cell
C0039195
C12543
Term relations
- Obinutuzumab
- Binetrakin
- hVEGF26-104/RFASE Peptide Vaccine
- Alefacept
- Lorukafusp alfa
- Recombinant Vaccinia-Mgp100 Vaccine
- Anti-GRP78 Monoclonal Antibody PAT-SM6
- HPV 18 E6:13-21 Peptide
- Anti-CD137 Agonistic Monoclonal Antibody CTX-471
- hTERT-encoding DNA Vaccine INVAC-1
- Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
- MAGE-A3-expressing Adenovirus Type 5 Vaccine
- hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
- Autologous Cytoplasmic Activated PD-1 CAR T-cells
- Attenuated Live Listeria monocytogenes Encoding KRAS G12D
- UV1 Telomerase Peptide Vaccine
- Long Peptide Vaccine 7
- 2G-1 TCR Retroviral Vector-Transduced Lymphocytes
- Immunocytokine NHS-IL2-LT
- P53-Synthetic Long Peptides Vaccine
- Anti-gp100 TCR Retroviral Vector-Transduced Autologous PBL
- Anti-gp100 TCR Retroviral Vector-Transduced Autologous TIL
- Anti-MART-1 TCR Retroviral Vector-Transduced Autologous TIL
- ESO-1 Reactive Autologous Peripheral Blood Lymphocyte
- PR-151 Peptide
- ESO-1 Reactive Autologous Tumor Infiltrating Lymphocyte
- VHL-59: 116-128 Peptide
- VHL-42: 65-76(V74G) Peptide
- gp100-Reactive Autologous Tumor Infiltrating Lymphocyte
- gp100-Reactive Autologous Peripheral Blood Lymphocyte
- SBIL-2 Transduced Autologous Tumor-Infiltrating Lymphocyte
- HPV 16 E6 (18-26) Peptide
- Anti-CD137 Agonistic Monoclonal Antibody ADG106
- Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
- HPV 16 E7:86-93 Peptide Vaccine
- MAGE-A3 Reactive T Cell Receptor-transduced Autologous T Cells
- Fowlpox-PSA-TRICOM Vaccine
- Rilimogene Galvacirepvec
- Daromun
- Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201
- Immunocytokine NHS-IL12
- IDH1R132H-Specific Peptide Vaccine PEPIDH1M
- HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c
- IDH1R132H Mutation-targeting IDH1 Peptide Vaccine
- Autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T-cells
- Galinpepimut-S
- Alpha-type-1 Polarized Dendritic Cells
- Gag:267-274 Peptide Vaccine
- Anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes
- Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300
- WT1 Analog Peptide Vaccine
- Recombinant Vaccinia-TRICOM Vaccine
- Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
- Recombinant Fowlpox-Prostate Specific Antigen Vaccine
- Recombinant Fowlpox-TRICOM Vaccine
- Recombinant Fowlpox-B7.1 Vaccine
- Ipilimumab
- Telomerase: 540-548 Peptide Vaccine
- Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
- Carcinoembryonic Antigen Peptide 1-6D
- Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
- PSA:154-163 Peptide
- PR6V10 (ras-12 Asp) Peptide
- PR-5V10 (ras-12 Val) Peptide
- PR7V10 (ras-12 Ala) Peptide
- PR-54 (ras-13 Asp) Peptide
- PCLUS 6.1-18MN
- PCLUS 3-18MN
- MART-1 Fowlpox Vaccine
- Monoclonal Antibody 95-6-22
- MART-1 Adenovirus Vaccine
- MART-1:26-35(27L) Peptide Vaccine
- MART-1:27-35 Peptide Vaccine
- MART-1 Vaccinia Vaccine
- KLH-Lymphoma Ig Vaccine
- gp100:209-217 Peptide
- gp100:17-25 Peptide
- gp100:280-288 Peptide Vaccine
- gp100-Pulsed Peripheral Blood Mononuclear Cell
- gp100:154-162 Peptide Vaccine
- gp100: ES209-217(210M) Peptide
- gp100 and GM-CSF DNA/Gold Vaccine
- Human gp100 Plasmid DNA Vaccine
- ESO-1:157-165(165V) Peptide
- gp100 Adenovirus Vaccine
- ALVAC-CEA (VCP248)
- Berzofsky Ras/P53 Peptide Vaccine
- B7 Transfected Melanoma Cell Vaccine
- VHL16 Peptide
- ALVAC-B7-CEA
- VHL14 Peptide
- Recombinant Vaccinia-MUC-1 Vaccine
- Tyrosinase:206-214 Peptide
- Tyrosinase:240-251(244S) Peptide
- VHL2 (Y12M) Peptide
- Tyrosinase:368-376(370D) Peptide
- Unconjugated Myeloma Ig Id
- Recombinant Fowlpox-Tyrosinase Vaccine
- Recombinant Fowlpox-gp100p209